PEAK PHARMACEUTICALS, INC. — Cash Flow Charts
22 quarters of history · ending 2017-06-30 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Net Debt Issuance
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-99.5% -$338K
$2K
Free Cash Flow↓-99.5% -$338K
$2K
Investing Cash Flow
$0
Financing Cash Flow
$0
Capex
$0
Stock Buybacks
$0
Stock-Based Comp
$0
Debt Issued
$0
D&A
$0
SBC Allocated Expense
$0